Clinical application of FDG-PET/CT in metastatic infections

被引：13

作者：

Kouijzer, Ilse J. ^{[1
]}

Vos, Fidel J. ^{[1
,2
]}

Bleker-Rovers, Chantal P. ^{[1
]}

Oyen, Wim J. ^{[3
]}

机构：

[1] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, POB 9101, Nijmegen, Netherlands

[2] Sint Maartensklin, Nijmegen, Netherlands

[3] Radboud Univ Nijmegen, Dept Radiol & Nucl Med, Med Ctr, Nijmegen, Netherlands

来源：

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 61卷 / 02期

关键词：

Fluorodeoxyglucose F18; Positron-emission tomography; Computed tomography; Metastatic infection; Bacteremia; Diagnostic imaging; POSITRON-EMISSION-TOMOGRAPHY; STAPHYLOCOCCUS-AUREUS BACTEREMIA; AORTIC GRAFT INFECTION; VASCULAR PROSTHESIS INFECTION; F-18-FDG PET/CT; VERTEBRAL OSTEOMYELITIS; LEUKOCYTE SCINTIGRAPHY; DIAGNOSIS; MANAGEMENT; VALVE;

D O I：

10.23736/S1824-4785.16.02735-7

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

FDG-PET/CT has proven its clinical value and cost-effectiveness in diagnosing metastatic infections in patients with Gram-positive bacteremia. In identification of metastatic foci, FDG-PET/CT is useful as a screening method when localizing symptoms are absent because it provides whole-body coverage. FDG-PET/CT detects early metabolic activity rather than the late anatomical changes as visualized by computed tomography and magnetic resonance imaging. FDG-PET/CT allows more precise localization of infection within a shorter time span between injection and diagnosis as compared to conventional nuclear imaging. This review focuses on the clinical application of imaging of metastatic infectious diseases, with an emphasis on FDG-PET/CT putting it in perspective with other imaging modalities.

引用

页码：232 / 246

页数：15

共 50 条

[11] Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica
Camellino, D.
Paparo, F.
Morbelli, S. D.
Pesce, G.
Bauckneht, M.
Bagnasco, M.
Cutolo, M.
Sambuceti, G.
Cimmino, M. A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (01) : 78 - 85
[12] FDG-PET/CT in Fever of Unknown Origin, Bacteremia, and Febrile Neutropenia
Hess, Soren
PET CLINICS, 2020, 15 (02) : 175 - +
[13] FDG-PET/CT in Inflammatory Bowel Disease: Is There a Future?
Brodersen, Jacob Broder
Hess, Soren
PET CLINICS, 2020, 15 (02) : 153 - +
[14] FDG-PET/CT for diagnosis of primary ovarian cancer
Kitajima, Kazuhiro
Suzuki, Kayo
Senda, Michio
Kita, Masato
Nakamoto, Yuji
Onishi, Yumiko
Maeda, Tetsuo
Yoshikawa, Takeshi
Ohno, Yoshiharu
Sugimura, Kazuro
NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (07) : 549 - 553
[15] Ability of FDG-PET/CT in the Detection of Gallbladder Cancer
Ramos-Font, Carlos
Gomez-Rio, Manuel
Rodriguez-Fernandez, Antonio
Jimenez-Heffernan, Amelia
Sanchez Sanchez, Rocio
Manuel Llamas-Elvira, Jose
JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (03) : 218 - 224
[16] Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation
Pijl, Jordy P.
Nienhuis, Pieter H.
Kwee, Thomas C.
Glaudemans, Andor W. J. M.
Slart, Riemer H. J. A.
Gormsen, Lars C.
SEMINARS IN NUCLEAR MEDICINE, 2021, 51 (06) : 633 - 645
[17] FDG-PET/CT as a molecular biomarker in ovarian cancer
Nowosinska, Ewa
Avril, Stefanie
Murray, Iain
Szyszko, Teresa
Avril, Norbert
CANCER BIOMARKERS, 2010, 8 (4-5) : 167 - 175
[18] Expert Consensus on clinical application of FDG PET/CT in infection and inflammation
Li, Yaming
Wang, Qian
Wang, Xuemei
Li, Xuena
Wu, Hua
Wang, Quanshi
Yao, Zhiming
Miao, Weibing
Zhu, Xiaohua
Hua, Fengchun
Zhang, Xiaoli
Cheng, Chao
Zhang, Weifang
Hou, Qingyi
Li, Yuan
Li, Xiao-Feng
ANNALS OF NUCLEAR MEDICINE, 2020, 34 (05) : 369 - 376
[19] Detection of Metastatic Involvement of the Pericardium on F-18 FDG-PET/CT Imaging
Douroukas, Anastasios
Arena, Vincenzo
Pelosi, Ettore
CLINICAL NUCLEAR MEDICINE, 2009, 34 (01) : 40 - 41
[20] Role of FDG-PET/CT for monitoring soft tissue tumors
Hoshi, Manabu
Oebisu, Naoto
Takada, Jun
Ieguchi, Makoto
Wakasa, Kenichi
Nakamura, Hiroaki
ONCOLOGY LETTERS, 2014, 7 (04) : 1243 - 1248

← 1 2 3 4 5 →